Abstract:Objective To analyze the epidemiological characteristics of inpatients with malignant tumors in a tertiary Chinese medicine hospital from 2017 to 2021, and to provide scientific evidence for the prevention and treatment of malignant tumors.Methods According to the International Classification of Diseases ICD-10, the information system of the homepage of hospital medical records was used to collect the information of inpatients with malignant tumors in a hospital from 2017 to 2021 for retrospective analysis. SPSS software was used for difference analysis and trend analysis.Results In 5 years, 6 377 eligible inpatients with malignant tumors were admitted including 3 758 male patients, accounting for 58.93%, and 2 619 female patients, accounting for 41.07%, with the gender ratio of male to female 1.43∶1. The most inpatients with malignant tumors were 60-69 years old, accounting for 25.81%. There were significant differences in the age distribution of malignant tumor patients with different genders (χ2 =101.91, P<0.001). The distribution of main malignant tumors in different age groups was different, and the difference was statistically significant (χ2=1 137.60, P<0.001). The average hospitalization days of malignant tumor patients were 13.14 days, with an average growth rate of 1.05%; the average cost per time was 24 728.74 yuan, with an average growth rate of 4.17%; the average daily hospitalization cost was 1 881.16 yuan, with an average growth rate of 3.02%. Among 6 377 patients with malignant tumors, 2 991 cases (46.90%) were in the top 10, which were as follows: hepatocellular carcinoma, upper lobe lung cancer, bronchial or lung cancer, thyroid cancer, breast cancer, prostate cancer, rectal cancer, and lower lobe lung cancer, sigmoid colon cancer, and multiple myeloma. In the top 10 malignant tumors, the longest average hospital stay was 15.26 days for multiple myeloma,and the highest average cost was 30 015.57 yuan for multiple myeloma.Conclusion There are gender and age differences in the composition of malignant tumors. Attention should be paid to male and elderly people,and different prevention and control measures should be adopted to reduce the incidence of malignant tumors, strengthen cost control, improve the quality of life, and reduce the burden on patients.
曾路情. 2017—2021年某三级甲等中医医院恶性肿瘤住院患者流行病学分析[J]. 中国医院统计, 2022, 29(6): 448-453.
Zeng Luqing. Epidemiological analysis of inpatients with malignant tumors in a tertiary Chinese medicine hospital from 2017 to 2021. journal1, 2022, 29(6): 448-453.
[1]WHO Cancer Mortality Database. International Agency for Rearch on Cancer[EB /OL].( 2021-03-09)[2022-06-05]. https://gco.iarc.fr/today/data /factsheets/populations/900world-fact-sheets.pdf.
[2]李恒,李韬.2012年—2016年某院恶性肿瘤住院患者流行病学分析[J].中国病案,2017,18(10):89-92.DOI:10.3969/j.issn.1672-2566.2017.10.032.
[3]曾心靛.湖南省某三甲医院2015—2019年消化系统恶性肿瘤住院患者流行病学分析[J].中国病案,2022,23(3):68-71.
[4]刘继巍,张启华.2017—2019年某市二级以上医疗机构恶性肿瘤住院患者疾病构成分析[J].中国医院统计,2021,28(5):420-425.DOI:10.3969/j.issn.1006-5253.2021.05.009.
[5]林恒娜,顾秀瑛,张思维,等.全球恶性肿瘤发病年龄分析[J].中华肿瘤杂志,2018,40(7):543-549.DOI:10.3760/cma.j.issn.0253-3766.2018.07.012.
[6]夏亮,许晓君,许燕君,等.2017年广东省珠江三角洲地区恶性肿瘤发病与死亡分析[J].中国肿瘤,2022,31(3):177-186.DOI:10.11735/j.issn.1004-0242.2022.03.A003.
[7]曾玉环,夏亮,许燕君,等.2014年广东省肿瘤登记地区恶性肿瘤发病和死亡分析[J].华南预防医学,2021,47(5):623-626.
[8]CHEN W Q, ZHENG S R, BAADE P, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[9]田国,边莉,徐小莉,等.肺癌患者发病情况和经济负担的分析[J].中国肺癌杂志,2022,25(3):167-173.DOI:10.3779/j.issn.1009-3419.2022.101.09.
[10]叶高.深圳市南山区2013—2020年甲状腺癌发病特征变化趋势分析[J].中外医学研究,2022,20(9):62-66.DOI:10.14033/j.cnki.cfmr.2022.09.018.
[11]MASSARWEH N N, ELSERAG H B. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Cancer Control, 2017, 24(3):1073274817729245. DOI:10.1177/1073274817729245.
[12]LIU Y Y, LIU Y K, HU W T, et al. Elevated heme impairs macrophage phagocytosis in endometriosis[J]. Reproduction, 2019, 158(3):257-266. DOI:10.1530/REP-19-0028.
[13]王贵强, 王福生, 庄辉,等. 慢性乙型肝炎防治指南:2019年版[J]. 临床肝胆病杂志, 2019, 35(12):41-62.
[14]涂爱仙,朱宏锐.海南省某三甲医院乳腺癌患者住院费用影响因素分析[J].中国医院统计,2022,29(2):125-129.DOI:10.3969/j.issn.1006-5253.2022.02.010.
[15]鲍萍萍,吴春晓.上海市癌症流行现况和防治实践[J].上海预防医学,2020,32(11):955-962.DOI:10.19428/j.cnki.sjpm.2020.19514.